(Q40528459)

English

A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer

scientific article published on August 2004

Statements

A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer (English)
Anthony W Tolcher
Jeffrey Kreisberg
Elzbieta Izbicka
Leslie Smetzer
Eric K Rowinsky

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit